Preferential effect of premorbid statins on atherothrombotic strokes through collateral circulation enhancement

European Neurology

Volumn 68, Issue 3, 2012, Pages 171-176

  Sargento Freitas, Joao ^a   Pagola, Jorge ^b   Rubiera, Marta ^b   Flores, Alan ^b   Silva, Fernando ^a   Rodriguez Luna, David ^b   Pineiro, Socorro ^b   Alvarez Sabn, Jose ^b   Molina, Carlos A ^b   Ribo, Marc ^b  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Acute stroke treatment; Atherosclerosis; Cerebral blood flow; Collateral pial circulation; Neuroimaging; Stroke; Thrombolysis

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ORAL ANTIDIABETIC AGENT;

AGED; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ATHEROSCLEROSIS; BRAIN INFARCTION SIZE; CARDIOEMBOLIC STROKE; CEREBROVASCULAR ACCIDENT; COLLATERAL CIRCULATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PIA ARTERY; PREDICTOR VARIABLE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; CAROTID ARTERY THROMBOSIS; COLLATERAL CIRCULATION; ENDOVASCULAR PROCEDURES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REPERFUSION; RETROSPECTIVE STUDIES; STROKE;

EID: 84865061507     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000337862     Document Type: Article

References (25)

1. Furlan A, Higashida R, Wechsler L, et al: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999; 282: 2003-2011.
2. Kim D, Jahan R, Starkman S, et al: Endovascular mechanical clot retrieval in a broad ischemic stroke cohort. AJNR Am J Neuroradiol 2006; 27: 2048-2052.
3. Amarenco P, Bogousslavsky J, Callahan A 3rd, et al: High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549-559.
4. Hart RG, Pearce LA, Aguilar MI: Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-867.
5. Rashid P, Leonardi-Bee J, Bath P: Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003; 34: 2741-2748.
6. Wilcox R, Bousser MG, Betteridge DJ, et al: Effects of pioglitazone in patients with type diabetes with or without previous stroke: results from PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04). Stroke 2007; 38: 865-873.
7. Sander D, Kearney MT: Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives. J Neurol 2009; 256: 1603-1619.
8. Paciaroni M, Bogousslavsky J: Primary and secondary prevention of ischemic stroke. Eur Neurol 2010; 63: 267-278.
9. Arboix A, Garcia-Eroles L, Oliveres M, Targa C, Balcells M, Massons J: Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia? BMC Neurol 2010; 10: 47.
10. Kumar S, Savitz S, Schlaug G, Caplan L, Selim M: Antiplatelets, ace inhibitors, and statins combination reduces stroke severity and tissue at risk. Neurology 2006; 66: 1153-1158.
11. Kunte H, Schmidt S, Eliasziw M, et al: Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke. Stroke 2007; 38: 2526-2530.
12. Audebert HJ, Schenk B, Schenkel J, Heuschmann PU: Impact of prestroke oral anticoagulation on severity and outcome of ischemic and hemorrhagic stroke in patients with atrial fibrillation. Cerebrovasc Dis 2010; 29: 476-483.
13. Matsumoto M, Okazaki S, Sakaguchi M, et al: Preadmission therapeutic anticoagulation reduces cerebral infarct volume in patients with nonvalvular atrial fibrillation. Eur Neurol 2011; 66: 277-282.
14. Bang OY, Saver JL, Kim SJ, et al: Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke 2011; 42: 693-699.
15. Ribo M, Flores A, Rubiera M, et al: Extending the time window for endovascular procedures according to collateral pial circulation. Stroke 2011; 42: 3465-3469.
16. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
17. Christoforidis GA, Mohammad Y, Kehagias D, Avutu B, Slivka AP: Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2005; 26: 1789-1797.
18. Van der Worp HB, Claus SP, Bar PR, et al: Reproducibility of measurements of cerebral infarct volume on CT scans. Stroke 2001; 32: 424-430.
19. Sallustio F, Diomedi M, Centonze D, Stanzione P: Saving the ischemic penumbra: potential role for statins and phosphodiesterase inhibitors. Curr Vasc Pharmacol 2007; 5: 259-265.
20. Murakami M, Fujioka S, Hirata Y, Kuratsu J: Low-dose of statin treatment improves cerebrovascular reactivity in patients with ischemic stroke: single photon emission computed tomography analysis. J Stroke Cerebrovasc Dis 2008; 17: 16-22.
21. Restrepo L, Bang OY, Ovbiagele B, et al: Impact of hyperlipidemia and statins on ischemic stroke outcomes after intra-arterial fibrinolysis and percutaneous mechanical embolectomy. Cerebrovasc Dis 2009; 28: 384-390.
22. Sata M, Nishimatsu H, Suzuki E, et al: Endothelial nitric oxide synthase is essential for the HMG-CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia. FASEB J 2001; 15: 2530-2532.
23. Ovbiagele B, Saver JL, Starkman S, et al: Statin enhancement of collateralization in acute stroke. Neurology 2007; 68: 2129-2131.
24. Nishikawa H, Miura S, Zhang B, et al: Pravastatin promotes coronary collateral circulation in patients with coronary artery disease. Coron Artery Dis 2002; 13: 377-381.
25. Smith WS, Sung G, Starkman S, et al: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the merci trial. Stroke 2005; 36: 1432-1438.